Portfolio company
MaxCyte
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
MaxCyte provides cell-engineering electroporation platforms and gene-editing assessment services for biopharmaceutical companies, research institutions and therapy developers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
Kytopen
This company develops non-viral gene delivery platforms for biotechnology researchers and pharmaceutical manufacturers to accelerate the production of gene-modified cell therapies.
ElevateBio, LLC
The company provides cell and gene therapy technologies, process development and manufacturing services to biotechnology and pharmaceutical firms.
CellFE
The company develops microfluidic platforms for intracellular delivery of molecules to support cell therapy developers and researchers in manufacturing engineered cells.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
Cytek
Cytek Biosciences manufactures cell analysis tools and flow cytometry systems for pharmaceutical companies, academic research institutions and contract research organisations.
Indee Labs
Indee Labs develops microfluidic cell engineering instruments for pharmaceutical and biotechnology companies to deliver gene-editing materials into immune cells for therapeutic development.
MFX
This company develops automated microfluidic bioreactor platforms and data generation infrastructure for researchers and manufacturers in the cell and gene therapy sector.
